Olodaterol	NN	Olodaterol O TermTag
shows	VBZ	show O TermTag
anti-fibrotic	JJ	anti-fibrotic O TermTag
efficacy	NN	efficacy O TermTag
in	IN	in O TermTag
in	FW	in O TermTag
vitro	FW	vitro O TermTag
and	CC	and O TermTag
in	FW	in O TermTag
vivo	FW	vivo O TermTag
models	NNS	model O TermTag
of	IN	of O TermTag
pulmonary	JJ	pulmonary O TermTag
fibrosis	NN	fibrosis O TermTag
.	.	. . NUPOS

BACKGROUND	NN	background O TermTag
AND	CC	and O TermTag
PURPOSE	NN	purpose O TermTag
:	:	: : NUPOS
Idiopathic	JJ	idiopathic O TermTag
pulmonary	JJ	pulmonary O TermTag
fibrosis	NN	fibrosis O TermTag
(	(	( ( NUPOS
IPF	NN	IPF O TermTag
)	)	) ) NUPOS
is	VBZ	be O TermTag
a	DT	a dt NUPOS
fatal	JJ	fatal O TermTag
respiratory	JJ	respiratory O TermTag
disease	NN	disease O TermTag
characterized	VBN	characterize O TermTag
by	IN	by O TermTag
excessive	JJ	excessive O TermTag
fibroblast	NN	fibroblast O TermTag
activation	NN	activation O TermTag
ultimately	RB	ultimate O TermTag
leading	VBG	lead O TermTag
to	TO	to O TermTag
scarring	NN	scarring O TermTag
of	IN	of O TermTag
the	DT	the O TermTag
lungs	NNS	lung O TermTag
.	.	. . NUPOS

Although	IN	although O TermTag
,	,	, , NUPOS
the	DT	the O TermTag
activation	NN	activation O TermTag
of	IN	of O TermTag
b2	NN	b2 O TermTag
--	:	-- O TermTag
adrenoceptors	NNS	adrenoceptor O TermTag
(	(	( ( NUPOS
b2	NN	b2 O TermTag
--	:	-- O TermTag
AR	NN	ar O TermTag
)	)	) ) NUPOS
has	VBZ	have O TermTag
been	VBN	be O TermTag
shown	VBN	show O TermTag
to	TO	to O TermTag
inhibit	VB	inhibit O TermTag
pro-fibrotic	JJ	pro-fibrotic O TermTag
events	NNS	event O TermTag
primarily	RB	primary O TermTag
in	IN	in O TermTag
cell	NN	cell O TermTag
lines	NNS	line O TermTag
,	,	, , NUPOS
the	DT	the O TermTag
role	NN	role O TermTag
of	IN	of O TermTag
b2	NN	b2 O TermTag
-	:	- : NUPOS
adrenoceptor	NN	adrenoceptor O TermTag
agonists	NNS	agonist O TermTag
has	VBZ	have O TermTag
not	RB	not O TermTag
yet	RB	yet O TermTag
been	VBN	be O TermTag
fully	RB	full O TermTag
characterized	VBN	characterize O TermTag
.	.	. . NUPOS

The	DT	the O TermTag
aim	NN	aim O TermTag
of	IN	of O TermTag
our	PRP$	our O TermTag
study	NN	study O TermTag
was	VBD	be O TermTag
to	TO	to O TermTag
explore	VB	explore O TermTag
the	DT	the O TermTag
anti-fibrotic	JJ	anti-fibrotic O TermTag
activity	NN	activity O TermTag
of	IN	of O TermTag
the	DT	the O TermTag
long-acting	JJ	long-acting O TermTag
b2	NN	b2 O TermTag
-	:	- : NUPOS
adrenoceptor	NN	adrenoceptor O TermTag
agonist	NN	agonist O TermTag
olodaterol	NN	olodaterol O TermTag
in	IN	in O TermTag
primary	JJ	primary O TermTag
human	JJ	human O TermTag
lung	NN	lung O TermTag
fibroblasts	NNS	fibroblast O TermTag
(	(	( ( NUPOS
HLF	NN	HLF GENE TermTag
)	)	) ) NUPOS
and	CC	and O TermTag
in	IN	in O TermTag
murine	JJ	murine O TermTag
models	NNS	model O TermTag
of	IN	of O TermTag
pulmonary	JJ	pulmonary O TermTag
fibrosis	NN	fibrosis O TermTag
.	.	. . NUPOS

EXPERIMENTAL	JJ	experimental O TermTag
APPROACH	NN	approach O TermTag
:	:	: : NUPOS
We	PRP	we O TermTag
assessed	VBD	assess O TermTag
the	DT	the O TermTag
activity	NN	activity O TermTag
of	IN	of O TermTag
olodaterol	NN	olodaterol O TermTag
to	TO	to O TermTag
inhibit	VB	inhibit O TermTag
various	JJ	various O TermTag
pro-fibrotic	JJ	pro-fibrotic O TermTag
mechanisms	NNS	mechanism O TermTag
,	,	, , NUPOS
induced	VBN	induce O TermTag
by	IN	by O TermTag
different	JJ	different O TermTag
pro-fibrotic	JJ	pro-fibrotic O TermTag
mediators	NNS	mediator O TermTag
,	,	, , NUPOS
in	IN	in O TermTag
primary	JJ	primary O TermTag
HLF	NN	HLF GENE TermTag
from	IN	from O TermTag
control	NN	control O TermTag
donors	NNS	donor O TermTag
and	CC	and O TermTag
patients	NNS	patient O TermTag
with	IN	with O TermTag
IPF	NN	IPF O TermTag
(	(	( ( NUPOS
IPF-LF	NN	IPF-LF O TermTag
)	)	) ) NUPOS
.	.	. . NUPOS

The	DT	the O TermTag
in	FW	in O TermTag
vivo	FW	vivo O TermTag
anti-fibrotic	JJ	anti-fibrotic O TermTag
activity	NN	activity O TermTag
of	IN	of O TermTag
olodaterol	NN	olodaterol O TermTag
,	,	, , NUPOS
given	VBN	give O TermTag
once	RB	once O TermTag
daily	RB	daily O TermTag
by	IN	by O TermTag
inhalation	NN	inhalation O TermTag
in	IN	in O TermTag
either	CC	either O TermTag
a	DT	a dt NUPOS
preventive	JJ	preventive O TermTag
or	CC	or O TermTag
therapeutic	JJ	therapeutic O TermTag
treatment	NN	treatment O TermTag
regimen	NN	regimen O TermTag
,	,	, , NUPOS
was	VBD	be O TermTag
explored	VBN	explore O TermTag
in	IN	in O TermTag
murine	JJ	murine O TermTag
models	NNS	model O TermTag
of	IN	of O TermTag
lung	NN	lung O TermTag
fibrosis	NN	fibrosis O TermTag
induced	VBN	induce O TermTag
by	IN	by O TermTag
either	CC	either O TermTag
bleomycin	NN	bleomycin O TermTag
or	CC	or O TermTag
the	DT	the O TermTag
overexpression	NN	overexpression O TermTag
of	IN	of O TermTag
TGF-b1	NN	TGF-b1 GENE TermTag
.	.	. . NUPOS

KEY	JJ	key O TermTag
RESULTS	NNS	result O TermTag
:	:	: : NUPOS
In	IN	in O TermTag
both	DT	both O TermTag
HLF	NN	HLF GENE TermTag
and	CC	and O TermTag
IPF-LF	NN	IPF-LF O TermTag
,	,	, , NUPOS
olodaterol	NN	olodaterol O TermTag
attenuated	VBD	attenuate O TermTag
TGF-b-induced	JJ	tgf-b-induced O TermTag
expression	NN	expression O TermTag
of	IN	of O TermTag
a-smooth-muscle-actin	NN	a-smooth-muscle-actin GENE TermTag
,	,	, , NUPOS
fibronectin	NN	fibronectin GENE TermTag
and	CC	and O TermTag
endothelin-1	NN	endothelin-1 GENE TermTag
(	(	( ( NUPOS
ET-1	NN	ET-1 GENE TermTag
)	)	) ) NUPOS
,	,	, , NUPOS
FGF	NN	FGF O TermTag
-	:	- : NUPOS
and	CC	and O TermTag
PDGF-induced	JJ	pdgf-induced O TermTag
motility	NN	motility O TermTag
and	CC	and O TermTag
proliferation	NN	proliferation O TermTag
and	CC	and O TermTag
TGF-b/ET	NN	TGF-b/ET O TermTag
-1-induced	JJ	-1-induced O TermTag
contraction	NN	contraction O TermTag
.	.	. . NUPOS

In	FW	in O TermTag
vivo	FW	vivo O TermTag
olodaterol	NN	olodaterol O TermTag
significantly	RB	significant O TermTag
attenuated	VBD	attenuate O TermTag
the	DT	the O TermTag
bleomycin-induced	JJ	bleomycin-induced O TermTag
increase	NN	increase O TermTag
in	IN	in O TermTag
lung	NN	lung O TermTag
weight	NN	weight O TermTag
,	,	, , NUPOS
reduced	VBD	reduce O TermTag
bronchoalveolar	JJ	bronchoalveolar O TermTag
lavage	NN	lavage O TermTag
cell	NN	cell O TermTag
counts	NNS	count O TermTag
and	CC	and O TermTag
inhibited	VBD	inhibit O TermTag
release	NN	release O TermTag
of	IN	of O TermTag
pro-fibrotic	JJ	pro-fibrotic O TermTag
mediators	NNS	mediator O TermTag
(	(	( ( NUPOS
TGF	NN	tgf O TermTag
-	:	- : NUPOS
,	,	, , NUPOS
MMP-9	NN	MMP-9 GENE TermTag
and	CC	and O TermTag
tissue	NN	tissue O TermTag
inhibitor	NN	inhibitor O TermTag
of	IN	of O TermTag
metalloproteinase-1	NN	metalloproteinase-1 O TermTag
)	)	) ) NUPOS
.	.	. . NUPOS

Forced	VBN	force O TermTag
vital	JJ	vital O TermTag
capacity	NN	capacity O TermTag
was	VBD	be O TermTag
increased	VBN	increase O TermTag
only	RB	only O TermTag
with	IN	with O TermTag
the	DT	the O TermTag
preventive	JJ	preventive O TermTag
treatment	NN	treatment O TermTag
regimen	NN	regimen O TermTag
.	.	. . NUPOS

In	IN	in O TermTag
the	DT	the O TermTag
TGF-b-overexpressing	JJ	tgf-b-overexpressing O TermTag
model	NN	model O TermTag
,	,	, , NUPOS
olodaterol	NN	olodaterol O TermTag
additionally	RB	additional O TermTag
reduced	VBD	reduce O TermTag
the	DT	the O TermTag
Col3A1	NN	Col3A1 O TermTag
mRNA	NN	mRNA O TermTag
expression	NN	expression O TermTag
.	.	. . NUPOS

CONCLUSION	NN	conclusion O TermTag
AND	CC	and O TermTag
IMPLICATIONS	NNS	implication O TermTag
:	:	: : NUPOS
Olodaterol	NN	Olodaterol O TermTag
showed	VBD	show O TermTag
anti-fibrotic	JJ	anti-fibrotic O TermTag
properties	NNS	property O TermTag
in	IN	in O TermTag
primary	JJ	primary O TermTag
HLF	NN	HLF GENE TermTag
from	IN	from O TermTag
control	NN	control O TermTag
and	CC	and O TermTag
IPF	NN	IPF O TermTag
patients	NNS	patient O TermTag
and	CC	and O TermTag
in	IN	in O TermTag
murine	JJ	murine O TermTag
models	NNS	model O TermTag
of	IN	of O TermTag
lung	NN	lung O TermTag
fibrosis	NN	fibrosis O TermTag
.	.	. . NUPOS

